Critical Role for the Chemokine Receptor CXCR6 in Homeostasis and Activation of CD1d-Restricted NKT Cells1
暂无分享,去创建一个
E. Butcher | Elitza S. Germanov | L. Veinotte | R. Cullen | E. Chamberlain | B. Johnston | Robyn Cullen | Elitza S Germanov
[1] M. Suematsu,et al. Critical Role for CXC Chemokine Ligand 16 (SR-PSOX) in Th1 Response Mediated by NKT Cells1 , 2007, The Journal of Immunology.
[2] G. Besra,et al. Peripheral NK1.1− NKT Cells Are Mature and Functionally Distinct from Their Thymic Counterparts1 , 2007, The Journal of Immunology.
[3] James J. Campbell,et al. iNKT Cells Require CCR4 to Localize to the Airways and to Induce Airway Hyperreactivity1 , 2007, The Journal of Immunology.
[4] M. Kronenberg,et al. The unique role of natural killer T cells in the response to microorganisms , 2007, Nature Reviews Microbiology.
[5] J. Stein‐Streilein,et al. Invariant NKT Cells and Tolerance , 2007, International reviews of immunology.
[6] M. Krummel,et al. Surface-bound chemokines capture and prime T cells for synapse formation , 2006, Nature Immunology.
[7] A. Viola,et al. T cells and their partners: The chemokine dating agency. , 2006, Trends in immunology.
[8] T. Fujisawa,et al. Natural killer T cell‐mediated antitumor immune responses and their clinical applications , 2006, Cancer science.
[9] R. Steinman,et al. Glycolipid α-C-galactosylceramide is a distinct inducer of dendritic cell function during innate and adaptive immune responses of mice , 2006 .
[10] M. Smyth,et al. Long-Term Retention of Mature NK1.1+ NKT Cells in the Thymus1 , 2006, The Journal of Immunology.
[11] B. Beghé,et al. Role for CXCR6 and its ligand CXCL16 in the pathogenesis of T-cell alveolitis in sarcoidosis. , 2005, American journal of respiratory and critical care medicine.
[12] D. Pellicci,et al. Differential antitumor immunity mediated by NKT cell subsets in vivo , 2005, The Journal of experimental medicine.
[13] N. Miyasaka,et al. Pathogenic role of the CXCL16-CXCR6 pathway in rheumatoid arthritis. , 2005, Arthritis and rheumatism.
[14] D. Wei,et al. Characterization of the early stages of thymic NKT cell development , 2005, The Journal of experimental medicine.
[15] N. Ohkohchi,et al. Cutting Edge: Critical Role of CXCL16/CXCR6 in NKT Cell Trafficking in Allograft Tolerance 1 , 2005, The Journal of Immunology.
[16] D. Wei,et al. Expansion and long-range differentiation of the NKT cell lineage in mice expressing CD1d exclusively on cortical thymocytes , 2005, The Journal of experimental medicine.
[17] Lisa M. Ebert,et al. Chemokine-mediated control of T cell traffic in lymphoid and peripheral tissues. , 2005, Molecular immunology.
[18] Mitchell Kronenberg,et al. Intravascular Immune Surveillance by CXCR6+ NKT Cells Patrolling Liver Sinusoids , 2005, PLoS biology.
[19] E. Butcher,et al. Role for CXCR6 in Recruitment of Activated CD8+ Lymphocytes to Inflamed Liver1 , 2005, The Journal of Immunology.
[20] A. Ploss,et al. Development of CD1d‐restricted NKT cells in the mouse thymus , 2004, European journal of immunology.
[21] J. Penninger,et al. Essential Role of LFA-1 in Activating Th2-Like Responses by α-Galactosylceramide-Activated NKT Cells1 , 2004, The Journal of Immunology.
[22] S. Sakoda,et al. Critical Roles of CXC Chemokine Ligand 16/Scavenger Receptor that Binds Phosphatidylserine and Oxidized Lipoprotein in the Pathogenesis of Both Acute and Adoptive Transfer Experimental Autoimmune Encephalomyelitis1 , 2004, The Journal of Immunology.
[23] L. Kaer,et al. NKT cells: what's in a name? , 2004, Nature Reviews Immunology.
[24] M. Smyth,et al. Glycolipid Antigen Drives Rapid Expansion and Sustained Cytokine Production by NK T Cells 1 , 2003, The Journal of Immunology.
[25] Mitchell Kronenberg,et al. Constitutive Cytokine mRNAs Mark Natural Killer (NK) and NK T Cells Poised for Rapid Effector Function , 2003, The Journal of experimental medicine.
[26] E. Butcher,et al. Differential Chemokine Responses and Homing Patterns of Murine TCRαβ NKT Cell Subsets 1 , 2003, The Journal of Immunology.
[27] E. Butcher,et al. Chemokines in the systemic organization of immunity , 2003, Immunological reviews.
[28] J. Strominger,et al. CD1d-Restricted NKT Cells Express a Chemokine Receptor Profile Indicative of Th1-Type Inflammatory Homing Cells 1 , 2003, The Journal of Immunology.
[29] G. Forni,et al. α-Galactosylceramide (KRN7000) suppression of chemical- and oncogene-dependent carcinogenesis , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[30] R. Locksley,et al. Mouse Vα14i natural killer T cells are resistant to cytokine polarization in vivo , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[31] E. Kunkel,et al. A Common Mucosal Chemokine (Mucosae-Associated Epithelial Chemokine/CCL28) Selectively Attracts IgA Plasmablasts 1 , 2003, The Journal of Immunology.
[32] R. Steinman,et al. Prolonged IFN-γ–producing NKT response induced with α-galactosylceramide–loaded DCs , 2002, Nature Immunology.
[33] E. Butcher,et al. Trafficking machinery of NKT cells: shared and differential chemokine receptor expression among Vα24+Vβ11+ NKT cell subsets with distinct cytokine-producing capacity , 2002 .
[34] E. Butcher,et al. Chemokines in rapid leukocyte adhesion triggering and migration. , 2002, Seminars in immunology.
[35] D. Pellicci,et al. A Natural Killer T (NKT) Cell Developmental Pathway Involving a Thymus-dependent NK1.1−CD4+ CD1d-dependent Precursor Stage , 2002, The Journal of experimental medicine.
[36] L. Teyton,et al. A Thymic Precursor to the NK T Cell Lineage , 2002, Science.
[37] I. Maričić,et al. Activation of Natural Killer T Cells Potentiates or Prevents Experimental Autoimmune Encephalomyelitis , 2001, The Journal of experimental medicine.
[38] L. Zitvogel,et al. Dendritic Cell Maturation Overrules H-2d–Mediated Natural Killer T (Nkt) Cell Inhibition , 2001, The Journal of experimental medicine.
[39] T. Yamamura,et al. A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells , 2001, Nature.
[40] M. Kronenberg,et al. NKT cells derive from double-positive thymocytes that are positively selected by CD1d , 2001, Nature Immunology.
[41] M. Kronenberg,et al. Activation of natural killer T cells by α-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes , 2001, Nature Medicine.
[42] F. Leithäuser,et al. Activating Immunity in the Liver. I. Liver Dendritic Cells (but Not Hepatocytes) Are Potent Activators of IFN-γ Release by Liver NKT Cells1 , 2001, The Journal of Immunology.
[43] I. Saiki,et al. Differential Regulation of Th1 and Th2 Functions of NKT Cells by CD28 and CD40 Costimulatory Pathways1 , 2001, The Journal of Immunology.
[44] D. Soler,et al. Expression Cloning of the STRL33/BONZO/TYMSTR Ligand Reveals Elements of CC, CXC, and CX3C Chemokines , 2001, The Journal of Immunology.
[45] E. Kunkel,et al. Bonzo/CXCR6 expression defines type 1-polarized T-cell subsets with extralymphoid tissue homing potential. , 2001, The Journal of clinical investigation.
[46] M. Smyth,et al. NKT cells: facts, functions and fallacies. , 2000, Immunology today.
[47] Sharon Engel,et al. A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo , 2000, Nature Immunology.
[48] E. Butcher,et al. The Primate Lentiviral Receptor Bonzo/STRL33 Is Coordinately Regulated with CCR5 and Its Expression Pattern Is Conserved Between Human and Mouse1 , 2000, The Journal of Immunology.
[49] M. Kronenberg,et al. Tracking the Response of Natural Killer T Cells to a Glycolipid Antigen Using Cd1d Tetramers , 2000, The Journal of experimental medicine.
[50] S. Snapper,et al. Activation of natural killer T cells by alpha-galactosylceramide in the presence of CD1d provides protection against colitis in mice. , 2000, Gastroenterology.
[51] L. Teyton,et al. In Vivo Identification of Glycolipid Antigen–Specific T Cells Using Fluorescent Cd1d Tetramers , 2000, The Journal of experimental medicine.
[52] D. Raulet,et al. NK1.1+ T Cells in the Liver Arise in the Thymus and Are Selected by Interactions with Class I Molecules on CD4+CD8+ Cells1 , 2000, The Journal of Immunology.
[53] M. Taniguchi,et al. Cutting edge: inhibition of experimental tumor metastasis by dendritic cells pulsed with alpha-galactosylceramide. , 1999, Journal of immunology.
[54] A. Ohta,et al. The Natural Killer T (NKT) Cell Ligand α-Galactosylceramide Demonstrates Its Immunopotentiating Effect by Inducing Interleukin (IL)-12 Production by Dendritic Cells and IL-12 Receptor Expression on NKT Cells , 1999, The Journal of experimental medicine.
[55] E. Butcher,et al. 6-C-kine (SLC), a Lymphocyte Adhesion-triggering Chemokine Expressed by High Endothelium, Is an Agonist for the MIP-3β Receptor CCR7 , 1998, The Journal of cell biology.
[56] Y. Tanaka,et al. Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Valpha14 NKT cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[57] T. Ohteki,et al. Lack of directed Vα14‐Jα281 rearrangements in NK1+ T cells , 1997 .
[58] O. Lantz,et al. An invariant T cell receptor alpha chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4-8- T cells in mice and humans , 1994, The Journal of experimental medicine.
[59] A. Lanzavecchia,et al. An invariant V alpha 24-J alpha Q/V beta 11 T cell receptor is expressed in all individuals by clonally expanded CD4-8- T cells , 1994, The Journal of experimental medicine.
[60] T. Pruett. Cutting Edge: Critical Role of CXCL16/CXCR6 in NKT Cell Trafficking in Allograft Tolerance , 2006 .
[61] Mitchell Kronenberg,et al. Toward an understanding of NKT cell biology: progress and paradoxes. , 2005, Annual review of immunology.
[62] L. Kaer. α-Galactosylceramide therapy for autoimmune diseases: prospects and obstacles , 2005, Nature Reviews Immunology.
[63] 千葉 麻子. Suppression of collagen-induced arthritis by natural killer T cell activation with OCH, a sphingosine-truncated analog of α-galactosylceramide , 2004 .
[64] H. Hashimoto,et al. Suppression of collagen-induced arthritis by natural killer T cell activation with OCH, a sphingosine-truncated analog of alpha-galactosylceramide. , 2004, Arthritis and rheumatism.
[65] Albert Bendelac,et al. An Invariant T Cell Receptor ~x Chain Is Used by a Unique Subset of Major Histocompatibility Complex Class I-specific Cd4 + and Cd4-8-t Cells in Mice and Humans , 1994 .